The number of people diagnosed with or dying from primary liver cancer per year could rise by more than 55 per cent by 2040, reveals a new analysis.
According to a new report, published in the Journal of Hepatology, countries must achieve at least a 3 per cent annual decrease in liver cancer incidence and mortality rates to avoid this increase.
"Liver cancer causes a huge burden of disease globally each year," said researcher Isabelle Soerjomataram, International Agency for Research on Cancer (IARC/WHO), Cancer Surveillance Branch, Lyon, France.
"It is also largely preventable if control efforts are prioritised major risk factors include hepatitis B virus, hepatitis C virus, alcohol consumption, excess body weight, and metabolic conditions including type 2 diabetes," Soerjomataram added.
For the research, the team extracted data on primary liver cancer cases and deaths from the International Agency for Research on Cancer's GLOBOCAN 2020 database, which produces cancer incidence and mortality estimates for 36 cancer types in 185 countries worldwide.
The predicted change in the number of cancer cases or deaths by the year 2040 was estimated using population projections produced by the UN.
Results showed that in 2020, an estimated 905,700 individuals were diagnosed with liver cancer and 830,200 died from liver cancer globally.
According to these data, liver cancer is now among the top three causes of cancer death in 46 countries and is among the top five causes of cancer death in nearly 100 countries, including several high-income countries.
Liver cancer incidence and mortality rates were highest in Eastern Asia, Northern Africa, and South-Eastern Asia. Investigators predict the annual number of new cases and deaths from liver cancer will rise by more than 55 per cent over the next 20 years, assuming current rates do not change.
Read More► Simple Swaps to Keep Your Heart Healthy
A sudden seasonal flu outbreak and an increase in Covid-19 cases have surprised many just as we were beginning to get used to the normalcy of a life without many constraints before the Covid virus.
An unavoidable flu wave generally coincides with a change in season. However, this season has witnessed an unanticipated increase in such cases-nearly doubling from last year in some areas-as well as harsher, Covid-like symptoms.
The spike of Covid-19 cases, the upcoming holiday season, and all of this together create a situation that specialists warn calls for ongoing precautions.
"Masks are the first line of defence against Covid-19 as well as other respiratory infections. With a spike in the number of infections, we must adhere to wearing masks when we step out in public areas. With the festive season right here and large gatherings inevitable, wearing masks are highly effective at reducing your risk of getting Covid as well as seasonal flu. Wearing the right kind of mask, the right way, is also extremely important," says Dr SC Ajmani, General Physician.
Your masks' kind and fit have a significant impact on how effective they are. According to research conducted by the Max Planck Institute for Dynamics and Self Organization in Germany, FFP2 masks that fit snugly offer 75 times more protection than surgical masks. By selecting these masks over common surgical or fabric masks, you greatly boost your protection and can leave the house more confidently, especially in crowded areas.
Protection from viruses, bacteria, dust, pollutants, allergens, and pollen (>= 0.3 micron) is offered by a BIS-approved FFP2 S mask like Savlon. These masks offer 95% protection from aerosols with particles larger than 0.3 micron. In comparison to standard masks, these masks include melt blown filters that are electro statically charged to provide enhanced filtering. The comfort and suitability of these masks for different skin types are also tested. Masks made with Savlon FFP2 S are BIS Certified.
According to BIS guidelines, each batch is put through rigorous testing for quality performance and efficacy. The effects of viruses, bacteria, dust, pollution, pollen, and allergies can be significantly minimised and the wearer's general health can be improved by donning a high-quality, properly fitted mask.
The correct masks are adjusted to perfectly fit on the bridge of your nose and to properly enclose your mouth and nose. We are aware that when an infected individual sneezes or coughs in a crowded environment, the Covid-19 virus as well as the seasonal influenza can spread quickly. First-level protection is unquestionably provided by donning a N95 or FFP2 S mask, especially for those with allergies, co-morbidities, impaired immune systems, or a higher propensity for experiencing severe symptoms.
The use of masks should become a way of life. We must continue using tried-and-true health strategies, like using masks in public. Keep your hygiene and health in mind.
Read More► Intermittent Fasting May Reduce Complications From Covid-19: Study
न्यूयॉर्क: उच्च रक्तचाप रहने से कोविड के टीकों की बूस्टर खुराक लेने के बावजूद ओमिक्रॉन-वेरिएंट के संक्रमण के कारण अस्पताल में भर्ती होने का जोखिम दोगुना से अधिक हो जाता है। एक नए शोध में यह निष्कर्ष निकाला गया है। हाइपरटेंशन जर्नल में प्रकाशित शोध निष्कर्ष के मुताबिक, हाई बीपी वाले व्यक्तियों को गंभीर कोविड संक्रमण के बाद अस्पताल में भर्ती कराने की जरूरत 2.6 गुना अधिक रहती है, भले ही उन्हें पहले से कोई और गंभीर बीमारी न हो।
सेंटर्स स्मिड्ट हार्ट इंस्टीट्यूट में कार्डियोलॉजी के सहायक प्रोफेसर लीड लेखक जोसेफ ई. एबिंगर ने कहा, "ब्रेकथ्रू ओमिक्रॉन संक्रमण गंभीर रूप से अस्पताल में भर्ती होने का कारण बन सकता है, यह किसी भी उम्र के वयस्क को हो सकता है, खासकर अगर किसी व्यक्ति को उच्च रक्तचाप है, भले ही उसे कोई अन्य बड़ी पुरानी बीमारी न हो।
शोधकर्ताओं ने 912 वयस्कों का पूर्वव्यापी अध्ययन किया, जिन्हें एमआरएनए कोविड वैक्सीन (या तो फाइजर-बायोएनटेक या मॉडर्न) की कम से कम तीन खुराक मिली थी और दिसंबर 2021 और अप्रैल 2022 के बीच ओमिक्रॉन के मामलों में उछाल के दौरान कोविड-19 का इलाज किया गया था।
विश्लेषण में पाया गया कि जिन 912 वयस्कों को एमआरएनए कोविड वैक्सीन की तीन खुराक मिली, उनमें से लगभग 16 प्रतिशत को अस्पताल में भर्ती होने की जरूरत थी। अस्पताल में भर्ती 145 मरीजों में से 125 (86.2 फीसदी) को हाई बीपी था।
एबिंगर ने कहा, "हमें जागरूकता और समझ बढ़ाने की जरूरत है कि एक टीके की तीन खुराक प्राप्त करने से सभी में गंभीर कोविड-19 को रोका नहीं जा सकता, खासकर उच्च रक्तचाप वाले लोगों में। हमें कोविड-19 और उच्च रक्तचाप के संबंध को समझने के लिए और अधिक शोध करने की जरूरत है।"
शोधकर्ताओं ने कहा कि आगे के अध्ययन में इस बात पर जोर दिया गया है कि गंभीर कोविड संक्रमण के जोखिम को कैसे कम किया जाए। (एजेंसी)
यह भी पढ़े► कोविड के लक्षणों में सिरदर्द सबसे आम : अध्ययन
Infection from the Omicron variant of Covid-19 is not mild as generally touted, rather is as deadly as Delta, Alpha and other strains that claimed thousands of lives globally, finds a study.
Omicron was first detected by South African scientists in November last year. It has previously been reported as more transmissible by a number of studies conducted in the UK, South Africa, Canada, and others, but less severe than other SARS-CoV-2 variants.
It was also reported to cause less hospitalisation and death. The highly contagious variant was found to affect the upper airways more than lungs, unlike Delta, causing common cold-like symptoms. However, the World Health Organization (WHO) warned several times that it should not be taken lightly.
But, the study led by the Massachusetts General Hospital and Harvard Medical School found that the risks of hospitalisation and mortality were "nearly identical between previous waves of Covid-19".
"Our analysis suggests that the intrinsic severity of the Omicron variant may be as severe as previous variants," the researchers claimed in the pre-print study, meaning not yet peer-reviewed.
Although there were reports noting Omicron's vaccine evading properties, the new study provided evidence that vaccines helped spare people from the worst impacts of Omicron.
In the study, the team linked state-level vaccination data with quality-controlled electronic health records from a large healthcare system, including 13 hospitals, in Massachusetts.
They then performed a weighted case-control study to compare risks of hospital admission and mortality across the SARS-CoV-2 waves in over 130,000 Covid patients.
The unadjusted rates of hospital admission and mortality appeared to be higher in previous waves compared to the Omicron period.
But, our findings suggest that after accounting for confounders, including various demographics, and vaccination status, "the Omicron variant was as deadly as the previous SARS-CoV-2 waves", wrote the researchers, including Zachary H. Strasse from MGH, in the study.
The team also acknowledged limitations in their report, including the possibility that the analysis underestimated the number of vaccinated patients in more recent Covid waves, and the total number of infections, because it excluded patients who performed at-home rapid tests. (Agency)
Read More► Double-Masking Does Not Improve Protection Against Covid: Study
Nearly 300 probable cases of children with severe hepatitis have been detected in 20 countries worldwide, with some in Southeast Asia, the World Health Organization (WHO) has said, BBC reported.
Health officials around the world are investigating a mysterious increase in cases of the liver condition which was first spotted in the UK.
A common virus called adenovirus, which has rebounded after the pandemic, could be causing the surge, BBC reported. One death has been reported by the WHO.
As of 1 May, it said most cases of young children with hepatitis had been detected in Europe with small numbers also reported in the Americas, western Pacific and Southeast Asia.
The first cases of this unusual hepatitis were spotted in Scotland in children under the age of 10. More than 110 cases have now been recorded in the UK so far.
Most children had a mild form of liver inflammation, although 10 children have needed a liver transplant, the report said.
They had initial symptoms of vomiting and diarrhoea followed by yellowing of the skin or whites of the eyes, called jaundice.
The hepatitis viruses that normally cause the condition (viruses A, B, C, D and E) were not detected in any of the children.
Countries worldwide started looking for the same unexplained condition 'of unknown origin' in children after it was highlighted by UK health officials.
There is no reason to believe the rare liver condition itself is spreading around the world, BBC reported. (Agency)
Read More► How to Maintain A Healthy Liver
Patna: The health department of Bihar on Thursday detected a new variant of Omicron in Indira Gandhi Institute of Medical Sciences (IGIMS).
The new variant BA.12 is 10 times more dangerous than BA.2 which was detected during the third wave of Corona in the country.
Prof Dr Namrata Kumari, the HOD of microbiology department of IGIMS, said: "Keeping in view the rising Covid cases, we had started genome sequencing of samples of Omicron variant of Corona. There were 13 samples tested and one of them had BA.12 strains. The remaining 12 samples have BA.2 strains."
"We have asked the authority for contact tracing of all the positive samples of Omicron. The BA.12 variant is 10 time more dangerous than BA.2. Though, there is no need to worry. Precaution is required here to protect from it," She said.
The BA.12 variant was first detected in the US. There were two to three cases detected in Delhi and now one case in Patna. (agency)
Read More► 6 in 10 People Continue to Suffer A Year After Covid Infection: Study
Dear Patron, Please provide additional information to validate your profile and continue to participate in engagement activities and purchase medicine.